Laurence Hicks - Net Worth and Insider Trading
Laurence Hicks Net Worth
The estimated net worth of Laurence Hicks is at least $2,979 dollars as of 2024-11-05. Laurence Hicks is the Director of Arch Therapeutics Inc and owns about 10,292 shares of Arch Therapeutics Inc (ARTH) stock worth over $2,979. Details can be seen in Laurence Hicks's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Laurence Hicks has not made any transactions after 2023-08-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Laurence Hicks
Laurence Hicks Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Laurence Hicks owns 1 companies in total, including Arch Therapeutics Inc (ARTH) .
Click here to see the complete history of Laurence Hicks’s form 4 insider trades.
Insider Ownership Summary of Laurence Hicks
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARTH | Arch Therapeutics Inc | 2023-08-31 | director |
Laurence Hicks Latest Holdings Summary
Laurence Hicks currently owns a total of 1 stock. Laurence Hicks owns 10,292 shares of Arch Therapeutics Inc (ARTH) as of August 31, 2023, with a value of $2,979.
Latest Holdings of Laurence Hicks
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARTH | Arch Therapeutics Inc | 2023-08-31 | 10,292 | 0.29 | 2,979 |
Holding Weightings of Laurence Hicks
Laurence Hicks Form 4 Trading Tracker
According to the SEC Form 4 filings, Laurence Hicks has made a total of 1 transactions in Arch Therapeutics Inc (ARTH) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Arch Therapeutics Inc is the acquisition of 10,292 shares on August 31, 2023, which cost Laurence Hicks around $2,882.
Insider Trading History of Laurence Hicks
- 1
Laurence Hicks Trading Performance
GuruFocus tracks the stock performance after each of Laurence Hicks's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Laurence Hicks is 335.37%. GuruFocus also compares Laurence Hicks's trading performance to market benchmark return within the same time period. The performance of stocks bought by Laurence Hicks within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Laurence Hicks's insider trading performs compared to the benchmark.
Performance of Laurence Hicks
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.56 | | | | | |
| Relative Return to S&P 500(%) | -6.69 | | | | | |
Laurence Hicks Ownership Network
Ownership Network List of Laurence Hicks
Ownership Network Relation of Laurence Hicks
Laurence Hicks Owned Company Details
What does Arch Therapeutics Inc do?
Who are the key executives at Arch Therapeutics Inc?
Laurence Hicks is the director of Arch Therapeutics Inc. Other key executives at Arch Therapeutics Inc include director & President & CEO Terrence W Norchi , CFO and Treasurer Michael S Abrams , and Vice President & Sales Dan Yrigoyen .
Arch Therapeutics Inc (ARTH) Insider Trades Summary
Over the past 18 months, Laurence Hicks made 1 insider transaction in Arch Therapeutics Inc (ARTH) with a net purchase of 10,292. Other recent insider transactions involving Arch Therapeutics Inc (ARTH) include a net purchase of 10,292 shares made by Michael S Abrams , a net purchase of 6,862 shares made by Terrence W Norchi ,
In summary, during the past 3 months, insiders sold 0 shares of Arch Therapeutics Inc (ARTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arch Therapeutics Inc (ARTH) were sold and 27,446 shares were bought by its insiders, resulting in a net purchase of 27,446 shares.
Arch Therapeutics Inc (ARTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arch Therapeutics Inc Insider Transactions
Laurence Hicks Mailing Address
Above is the net worth, insider trading, and ownership report for Laurence Hicks. You might contact Laurence Hicks via mailing address: C/o Arch Therapeutics, Inc., 235 Walnut Street, Suite 6, Framingham Ma 01702.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
